Search

Protecting patents and maximizing their value are paramount to the success of brand pharmaceutical companies and university technology departments, in particular as they relate to generic competitors who file Abbreviated New Drug Applications (ANDAs) under the Hatch-Waxman Act. Saul Ewing’s...

Intellectual property is often a company’s strongest asset, one that can be protected and leveraged to gain a competitive advantage. It is critical for companies of all sizes to effectively protect and enforce their intellectual property. Saul Ewing’s team of attorneys and patent agents with diverse...

Sarah Sullivan represents pharmaceutical companies involved in complex, high stakes patent litigation. Sarah concentrates her practice on Hatch-Waxman ANDA cases and disputes over the intellectual property behind branded pharmaceuticals. She is part of the Firm's nationally-recognized team for...

Ian McLin concentrates his practice in complex civil litigation, including business torts and contract disputes. His experience spans state and federal courts and includes preparing pleadings, drafting motions, taking depositions, and arguing motions. Ian also provides guidance regarding complex...

Dennis Ostrovsky assists clients with patent portfolios involving obtaining patents in diverse technologies such as nanomaterials, cellular analysis systems, small molecule drugs, bactericides, abrasives, drug delivery systems, dental compositions, volumetric additive manufacturing (VAM), OLED...